News Headlines Article

Growing problem of fake drugs endangers consumers’ health
USA Today

Counterfeit drugs made in Asia and other emerging markets are a growing problem that’s endangering consumers’ health and chipping away at drug companies’ profits. Last year, nearly 1,700 incidents of counterfeit drugs were reported worldwide, triple the number in 2004, says the Pharmaceutical Security Institute (PSI), a group funded by drugmakers. Estimates for the size of the counterfeit drug market range from $75 billion to $200 billion a year. The market is likely much bigger because many cases are hard to detect.

Commands